CLINICAL TRIAL SUMMARY

MDACC Study No:2013-0590 (clinicaltrials.gov NCT No: NCT02010645)
Title:Phase II Study of Eltrombopag in Combination with Decitabine in Subjects with Advanced Myelodysplastic Syndrome
Principal Investigator:Courtney DiNardo
Treatment Agent:Decitabine; Eltrombopag
Study Status:Open
Study Description:The goal of this clinical research study is to learn if eltrombopag given in
combination with decitabine can help to control advanced MDS. The safety of
this study drug combination will also be studied.

Hide details for General InformationGeneral Information

Disease Group:Leukemia
Phase of Study:Phase II
Treatment Agents:Decitabine
Eltrombopag
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:
Supported By:GlaxoSmithKline
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Courtney DiNardo
Dept:Leukemia
For Clinical Trial Enrollment:713-794-1141
For General Questions about Clinical Trials:1-877-MDA-6789


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults